Medicare Costs for Cancer Drugs Nearly Doubled in Past 4 Years Medicare Costs for Cancer Drugs Nearly Doubled in Past 4 Years

Medicare spending on oncology drugs per beneficiary nearly doubled from 2016 to 2020, although the number of patients using these drugs has remained fairly stable.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news